2024 Fiscal Year Annual Research Report
虚血性心筋を標的とするナノボディ修飾細胞外小胞を使用した心筋梗塞治療法の開発
| Project/Area Number |
22K20643
|
| Research Institution | Shonan Kamakura General Hospital, Medical Corporation Tokushukai (Center for Clinical and |
Principal Investigator |
ヤン ジュンジー 医療法人徳洲会湘南鎌倉総合病院(臨床研究センター), 湘南先端医学研究所 再生医療開発研究部, 主任研究員 (20962137)
|
| Project Period (FY) |
2022-08-31 – 2025-03-31
|
| Keywords | FoxM1 / targeted delivery / endothelial regeneration / myocardial infarction / cell cycle |
| Outline of Annual Research Achievements |
We evaluated the therapeutic potential of endothelial-targeted FoxM1 gene delivery in a mouse model of myocardial infarction (MI). Using nanoparticles conjugated with plasmids driven by the endothelial-specific Cdh5 promoter, we selectively overexpressed FoxM1 in endothelial cells. Echocardiography showed improved cardiac function in FoxM1-treated mice. Immunostaining revealed increased endothelial cell proliferation and capillary density. RT-qPCR showed upregulation of angiogenic and cell cycle-related genes. HE staining demonstrated reduced neutrophil infiltration. These results indicate that FoxM1 promotes endothelial regeneration, reduces inflammation, and enhances cardiac repair after MI.
|